World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
20087
World Ranking
8516
National Ranking
3831

Kojo S.J. Elenitoba-Johnson publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Kojo S.J. Elenitoba-Johnson sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 277 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Kojo S.J. Elenitoba-Johnson D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Kojo S.J. Elenitoba-Johnson sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 66 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Kojo S.J. Elenitoba-Johnson is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on areas within Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in Molecular Biology, Pathology and Forensic Medicine, Genetics, Oncology, and Cancer Research.

The scientist's work encompasses several main topics including:

  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Ubiquitin and proteasome pathways
  • Cancer Genomics and Diagnostics
  • Viral-associated cancers and disorders
  • Cutaneous lymphoproliferative disorders research
  • Cancer-related gene regulation

Kojo S.J. Elenitoba-Johnson has published extensively in prominent journals. Frequent publication venues include:

  • Blood (11 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (4 publications)
  • Leukemia (2 publications)
  • Blood Advances (2 publications)
  • Cancer Discovery (2 publications)

Notable recent papers authored by the scientist include:

  • "The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms", 2022, Leukemia
  • "International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease," 2020, Blood Advances
  • "Mastermind: A Comprehensive Genomic Association Search Engine for Empirical Evidence Curation and Genetic Variant Interpretation," 2020, Frontiers in Genetics
  • "Enabling Precision Oncology Through Precision Diagnostics," 2020, Annual Review of Pathology Mechanisms of Disease
  • "Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748," 2023, Leukemia

The scientist collaborates frequently with a core group of co-authors including Megan S. Lim, Özlem Önder, Rui Wu, Anagh A. Sahasrabuddhe, and Vinodh Pillai. These partnerships contribute to the interdisciplinary nature of their research and its application across hematologic malignancies and molecular diagnostics.

Best Publications

  • ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor.

    Cheryl M. Coffin;Ankita Patel;Sherrie Perkins;Kojo S J Elenitoba-Johnson

  • International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

    David C. Fajgenbaum;Thomas S. Uldrick;Adam Bagg;Dale Frank

  • CGG Repeat-Associated Translation Mediates Neurodegeneration in Fragile X Tremor Ataxia Syndrome

    Peter K. Todd;Seok Yoon Oh;Amy Krans;Fang He

  • Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.

    J. Chad Brenner;Bushra Ateeq;Yong Li;Anastasia K. Yocum

  • Real-time multiplex PCR assays.

    Carl T. Wittwer;Mark G. Herrmann;Cameron N. Gundry;Kojo S.J. Elenitoba-Johnson

  • Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.

    Charu Aggarwal;Jeffrey C. Thompson;Taylor A. Black;Sharyn I. Katz

  • International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

    Frits Van Rhee;Peter Voorhees;Angela Dispenzieri;Alexander Fosså

  • Anaplastic Large Cell Lymphoma.

    L. Jeffrey Medeiros;Kojo S.J. Elenitoba-Johnson

  • High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis.

    Noah A. Brown;Larissa V. Furtado;Bryan L. Betz;Mark J. Kiel

  • Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma

    Mark J. Kiel;Thirunavukkarasu Velusamy;Bryan L. Betz;Lili Zhao

  • Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes

    Shimareet Kumar;Lazlo Krenacs;Jeffrey Medeiros;Kojo S.J Elenitoba-Johnson

  • Pathological Findings in Human Autoimmune Lymphoproliferative Syndrome

    Megan S. Lim;Stephen E. Straus;Janet K. Dale;Thomas A. Fleisher

  • Activating FGFR2-RAS-BRAF mutations in ameloblastoma.

    Noah A. Brown;Delphine Cm Rolland;Jonathan B. McHugh;Helmut C. Weigelin

  • The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.

    Andrew G. Muntean;Jiaying Tan;Kajal Sitwala;Yongsheng Huang

  • Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

    Mark J. Kiel;Thirunavukkarasu Velusamy;Delphine Rolland;Anagh A. Sahasrabuddhe

  • Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis.

    Thomas A. Milne;Jaehoon Kim;Gang G. Wang;Sonja C. Stadler

  • Homozygous Deletions at Chromosome 9p21 Involving p16 and p15 Are Associated With Histologic Progression in Follicle Center Lymphoma

    Kojo S.J. Elenitoba-Johnson;Randy D. Gascoyne;Megan S. Lim;Mukesh Chhanabai

  • Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy

    Kojo S. J. Elenitoba-Johnson;Stephen D. Jenson;Robert T. Abbott;Robert A. Palais

  • High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia

    Helen McCarthy;William G. Wierda;William G. Wierda;Lynn L. Barron;Lynn L. Barron;Candy C. Cromwell;Candy C. Cromwell

  • High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma.

    Aaron M. Udager;Delphine C.M. Rolland;Jonathan B. McHugh;Bryan L. Betz

Frequent Co-Authors

Megan S. Lim
Megan S. Lim University of Pennsylvania
Mitchell S. Cairo
Mitchell S. Cairo New York Medical College
L. Jeffrey Medeiros
L. Jeffrey Medeiros The University of Texas MD Anderson Cancer Center
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Henry L. Paulson
Henry L. Paulson University of Michigan–Ann Arbor
Alexey I. Nesvizhskii
Alexey I. Nesvizhskii University of Michigan–Ann Arbor
Michele Pagano
Michele Pagano New York University
Yoon Kyung Jeon
Yoon Kyung Jeon Seoul National University Hospital
Carl T. Wittwer
Carl T. Wittwer University of Utah
Nallasivam Palanisamy
Nallasivam Palanisamy Henry Ford Health System

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Biology and Biochemistry opens doors to a wide range of online degree options and healthcare careers. For those interested in clinical practice, there are many paths that start with foundational courses and build toward advanced roles. Many students begin with online medical assisting classes, which provide entry-level skills to work in healthcare environments.

Career advancement is also possible through bridge programs. If you are a medical assistant aiming to become a licensed nurse, consider ma to lpn bridge programs online. These programs help you transition smoothly and expand your scope of practice in less time.

For those passionate about science, online biology degree programs allow you to earn your degree at your own pace. These flexible options are ideal for learners balancing education with work or family.

Additionally, starting with an online asn program can fast-track your journey into nursing. This gives you the opportunity to start working in healthcare sooner and build experience while continuing your studies.

Best Scientists Citing Kojo S.J. Elenitoba-Johnson

Trending Scientists